All terms in GO

Label Id Description
GO_0060139 GO_0060139
maternal process involved in parturition GO_0060137 [A reproductive process occurring in the mother that results in birth.]
regulation of tube length, open tracheal system GO_0035159 [Ensuring that a tube in an open tracheal system is of the correct length.]
fetal process involved in parturition GO_0060138 [A reproductive process occurring in the embryo that results in birth.]
positive regulation of antibody-dependent cellular cytotoxicity GO_0001815 [Any process that activates or increases the frequency, rate or extent of antibody-dependent cellular cytotoxicity.]
regulation of antibody-dependent cellular cytotoxicity GO_0001813 [Any process that modulates the frequency, rate, or extent of antibody-dependent cellular cytotoxicity.]
FYXD domain binding GO_0098750 [Binding to a FXYD domain.]
negative regulation of antibody-dependent cellular cytotoxicity GO_0001814 [Any process that stops, prevents, or reduces the rate of antibody-dependent cellular cytotoxicity.]
bone cell development GO_0098751 [The process whose specific outcome is the progression of a bone cell over time, from initial commitment of the cell to a specific fate, to the fully functional differentiated cell.]
terminal cell fate specification, open tracheal system GO_0035154 [The process in which a cell in an open tracheal system becomes capable of differentiating autonomously into a terminal cell in an environment that is neutral with respect to the developmental pathway; upon specification, the cell fate can be reversed. Terminal cells send long and bifurcated hollow branches toward target tissues to allow oxygen exchange.]
negative regulation of type I hypersensitivity GO_0001811 [Any process that stops, prevents, or reduces the rate of type I hypersensitivity, a type of inflammatory response.]
regulation of type I hypersensitivity GO_0001810 [Any process that modulates the frequency, rate, or extent of type I hypersensitivity, a type of inflammatory response.]
negative regulation of hypersensitivity GO_0002884 [Any process that stops, prevents, or reduces the frequency, rate, or extent of hypersensitivity.]
obsolete integral component of the cytoplasmic side of the plasma membrane GO_0098752 [OBSOLETE. The component of the plasma membrane consisting of the gene products that penetrate only the cytoplasmic side of the membrane.]
positive regulation of type I hypersensitivity GO_0001812 [Any process that activates or increases the frequency, rate or extent of type I hypersensitivity, a type of inflammatory response.]
positive regulation of hypersensitivity GO_0002885 [Any process that activates or increases the frequency, rate, or extent of hypersensitivity.]
obsolete anchored component of the cytoplasmic side of the plasma membrane GO_0098753 [OBSOLETE. The component of the plasma membrane consisting of gene products and protein complexes with covalently attached hydrophobic anchors products that penetrate only the cytoplasmic side of the membrane.]
regulation of hypersensitivity GO_0002883 [Any process that modulates the frequency, rate, or extent of hypersensitivity.]
maintenance of seed dormancy by absisic acid GO_0098755 [The process by which seed dormancy is maintained by the presence of absisic acid.]
response to interleukin-21 GO_0098756 [Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interleukin-21 stimulus.]